Page:United States Statutes at Large Volume 124.djvu/1090

124 STAT. 1064 PUBLIC LAW 111–152—MAR. 30, 2010 SEC. 1404. BRAND NAME PHARMACEUTICALS. (a) IN GENERAL.—Section 9008 of the Patient Protection and Affordable Care Act is amended— (1) in subsection (a)(1), by striking ‘‘2009’’ and inserting ‘‘2010’’; (2) in subsection (b)— (A) by striking ‘‘$2,300,000,000’’ in paragraph (1) and inserting ‘‘the applicable amount’’; and (B) by adding at the end the following new paragraph: ‘‘(4) APPLICABLE AMOUNT.—For purposes of paragraph (1), the applicable amount shall be determined in accordance with the following table: ‘‘Calendar year Applicable amount 2011 ............................................................................... $2,500,000,000 2012 ............................................................................... $2,800,000,000 2013 ............................................................................... $2,800,000,000 2014 ............................................................................... $3,000,000,000 2015 ............................................................................... $3,000,000,000 2016 ............................................................................... $3,000,000,000 2017 ............................................................................... $4,000,000,000 2018 ............................................................................... $4,100,000,000 2019 and thereafter ...................................................... $2,800,000,000.’’; (3) in subsection (d), by adding at the end the following new paragraph: ‘‘(3) JOINT AND SEVERAL LIABILITY.—If more than one per- son is liable for payment of the fee under subsection (a) with respect to a single covered entity by reason of the application of paragraph (2), all such persons shall be jointly and severally liable for payment of such fee.’’; and (4) by striking subsection (j) and inserting the following new subsection: ‘‘(j) EFFECTIVE DATE.—This section shall apply to calendar years beginning after December 31, 2010.’’. (b) EFFECTIVE DATE.—The amendments made by this section shall take effect as if included in section 9008 of the Patient Protec- tion and Affordable Care Act. SEC. 1405. EXCISE TAX ON MEDICAL DEVICE MANUFACTURERS. (a) IN GENERAL.—Chapter 32 of the Internal Revenue Code of 1986 is amended— (1) by inserting after subchapter D the following new sub- chapter: ‘‘Subchapter E—Medical Devices ‘‘Sec. 4191. Medical devices. ‘‘SEC. 4191. MEDICAL DEVICES. ‘‘(a) IN GENERAL.—There is hereby imposed on the sale of any taxable medical device by the manufacturer, producer, or importer a tax equal to 2.3 percent of the price for which so sold. ‘‘(b) TAXABLE MEDICAL DEVICE.—For purposes of this section— ‘‘(1) IN GENERAL.—The term ‘taxable medical device’ means any device (as defined in section 201(h) of the Federal Food, Drug, and Cosmetic Act) intended for humans. ‘‘(2) EXEMPTIONS.—Such term shall not include— Definition. 26 USC 4191. 26 USC 4001 note prec. Ante, p. 859.